A new study casts some doubt on the benefits of Zetia, a cholesterol-lowering drug that about 1 million people in the U.S. use. The "Enhance" trial studied a combination of Zetia and the statin drug ...
ORLANDO, Nov 15 (Reuters) - Abbott Laboratories' Niaspan appeared to be more effective and safer than Merck & Co's Zetia as a supplementary cholesterol treatment to statins, according to a small study ...
ORLANDO, Nov 15 (Reuters) - Abbott Laboratories' Niaspan appeared to be more effective and safer than Merck & Co's Zetia as a supplementary cholesterol treatment to statins, according to a small study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results